Tech Center 1600 • Art Units: 1600 1611 1618
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17365733 | DESIGN AND DEVELOPMENT OF NEUROKININ-1 RECEPTOR-BINDING AGENT DELIVERY CONJUGATES | Final Rejection | Purdue Research Foundation |
| 17539442 | METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS | Final Rejection | BRISTOL-MYERS SQUIBB COMPANY |
| 17712479 | PLASMONICS-ACTIVE METAL NANOSTAR COMPOSITIONS AND METHODS OF USE | Non-Final OA | Duke University |
| 17294375 | MACROCYCLIC COMPLEXES OF RADIONUCLIDES AND THEIR USE IN RADIOTHERAPY OF CANCER | Non-Final OA | Cornell University |
| 17053691 | MAGNETIC LIPOSOMES AND RELATED TREATMENT AND IMAGING METHODS | Non-Final OA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED |
| 16964733 | CONJUGATABLE DESMOGLEIN 2 (DSG2) BINDING PROTEINS AND USES THEREFOR | Final Rejection | HDT BIO CORP. |
| 17264944 | POLYPEPTIDE DELIVERY COMPOSITION | Non-Final OA | LEMONEX INC. |
| 18109031 | Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications | Final Rejection | InFlectis BioScience |
| 17914061 | INHALED XENON THERAPY IN NEURODEGENERATIVE DISEASE | Final Rejection | General Biophysics LLC |
| 17484727 | Enhanced in Vivo Targeting of Site-Specific Drugs | Non-Final OA | Advanced Accelerator Applications USA, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy